ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT

被引:0
作者
Martomo, Stella [1 ]
Wang, George [1 ]
Polonskaya, Zhanna [1 ]
Luna, Xenia [1 ]
Lu, Dan [1 ]
Patel, Jeegar [1 ]
机构
[1] Kadmon Corp, New York, NY USA
关键词
D O I
10.1136/jitc-2021-SITC2021.652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
652
引用
收藏
页码:A681 / A681
页数:1
相关论文
共 50 条
[41]   Peritumoral IL-15 Promotes Regional NK Activation and DC Licensing to Augment Radiation-Induced Anti-tumor Immunity [J].
Pilones, K. A. ;
Daviaud, C. ;
Garcia-Martinez, H. ;
Formenti, S. C. ;
Demaria, S. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02) :S162-S162
[42]   Multimodal cancer immunotherapy combining IL-8 inhibition, adenovirus vaccine, IL-15 super agonist, and anti-PD-L1/TGFβRII agent reduces mesenchymalization and enhances anti-tumor efficacy. [J].
Horn, Lucas ;
Hamilton, Duane ;
Maeda, Dean ;
Zebala, John ;
Lee, John ;
Rabizadeh, Shahrooz ;
Jones, Frank ;
Soon-Shiong, Patrick ;
Su, Zhen ;
Schlom, Jeffrey ;
Palena, Claudia .
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) :84-85
[43]   HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression [J].
Xiaolei Li ;
Xiao Su ;
Rui Liu ;
Yongsha Pan ;
Jiankai Fang ;
Lijuan Cao ;
Chao Feng ;
Qianwen Shang ;
Yongjing Chen ;
Changshun Shao ;
Yufang Shi .
Oncogene, 2021, 40 :1836-1850
[44]   HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression [J].
Li, Xiaolei ;
Su, Xiao ;
Liu, Rui ;
Pan, Yongsha ;
Fang, Jiankai ;
Cao, Lijuan ;
Feng, Chao ;
Shang, Qianwen ;
Chen, Yongjing ;
Shao, Changshun ;
Shi, Yufang .
ONCOGENE, 2021, 40 (10) :1836-1850
[45]   The role of tumor microenvironment lactic acid in the cancer cell resistance to anti-PD-L1 and anti-PD-1 blockade therapy [J].
Kim, Alyssa ;
Oh, Wonkyung ;
Dhawan, Deepika ;
Knapp, Deborah W. ;
Lim, Seung-Oe .
CANCER RESEARCH, 2025, 85 (08)
[46]   Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma [J].
Kang, Seong-Ho ;
Keam, Bhumsuk ;
Ahn, Yong-Oon ;
Park, Ha-Ram ;
Kim, Miso ;
Kim, Tae Min ;
Kim, Dong-Wan ;
Heo, Dae Seog .
ONCOIMMUNOLOGY, 2019, 8 (01)
[47]   Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models [J].
Borodovsky, Alexandra ;
Wang, Yanjun ;
Ye, Minwei ;
Shaw, Joseph C. ;
Sachsenmeier, Kris ;
Deng, Nanhua ;
Goodwin, Kelly ;
Clarke, James D. ;
Goodwin, Richard ;
Strittmatter, Nicole ;
Hay, Carl ;
Sah, Vasu ;
Deborah, Lawson ;
Reimer, Corinne ;
Congreve, Miles ;
Mason, Jonathan ;
Marshall, Fiona ;
Lyne, Paul ;
Woessner, Richard .
CANCER RESEARCH, 2018, 78 (13)
[48]   Lentinan-laden microspheres reprogram the tumor microenvironment and improve anti-PD-L1 efficacy [J].
Wang, Haixin ;
Gao, Xiao-Dong ;
Yue, Hua .
JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (20) :4475-4484
[49]   Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer [J].
Li, Xiuying ;
Luo, Xianqin ;
Hu, Shunqin .
BIOIMPACTS, 2023, 13 (02) :89-96
[50]   Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity [J].
Shi, Wenqiang ;
Liu, Nan ;
Liu, Zexin ;
Yang, Yuqi ;
Zeng, Qiongya ;
Wang, Yang ;
Song, Luyao ;
Hu, Fang ;
Fu, Jin ;
Chen, Junsheng ;
Wu, Mingyuan ;
Zhou, Lin ;
Zhu, Fengping ;
Gong, Likun ;
Zhu, Jianwei ;
Jiang, Long ;
Lu, Huili .
CELL REPORTS MEDICINE, 2024, 5 (05)